289 related articles for article (PubMed ID: 18784147)
1. Renal manifestations of systemic sclerosis--clinical features and outcome assessment.
Denton CP
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v54-6. PubMed ID: 18784147
[TBL] [Abstract][Full Text] [Related]
2. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
[TBL] [Abstract][Full Text] [Related]
3. Kidney disease other than renal crisis in patients with diffuse scleroderma.
Steen VD; Syzd A; Johnson JP; Greenberg A; Medsger TA
J Rheumatol; 2005 Apr; 32(4):649-55. PubMed ID: 15801020
[TBL] [Abstract][Full Text] [Related]
4. Scleroderma renal crisis: patient characteristics and long-term outcomes.
Penn H; Howie AJ; Kingdon EJ; Bunn CC; Stratton RJ; Black CM; Burns A; Denton CP
QJM; 2007 Aug; 100(8):485-94. PubMed ID: 17601770
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis, management and prevention of scleroderma renal disease.
Penn H; Denton CP
Curr Opin Rheumatol; 2008 Nov; 20(6):692-6. PubMed ID: 18946330
[TBL] [Abstract][Full Text] [Related]
6. Kidney crisis in systemic sclerosis.
Lewandowski B; Domysławska I; Klimiuk PA; Sierakowski S
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():294-6. PubMed ID: 16119690
[TBL] [Abstract][Full Text] [Related]
7. [A patient with systemic scleroderma showing improvement during long-term hemodialysis after renal crisis].
Fuse Y; Muramatsu M; Sugiyama S; Maeda K
Ryumachi; 1997 Aug; 37(4):574-80. PubMed ID: 9311284
[TBL] [Abstract][Full Text] [Related]
8. [Renal involvement in patients with systemic sclerosis].
Bussone G; Noël LH; Mouthon L
Nephrol Ther; 2011 Jun; 7(3):192-9. PubMed ID: 21524952
[TBL] [Abstract][Full Text] [Related]
9. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
Teixeira L; Mouthon L; Mahr A; Berezné A; Agard C; Mehrenberger M; Noël LH; Trolliet P; Frances C; Cabane J; Guillevin L;
Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
[TBL] [Abstract][Full Text] [Related]
10. [Renal involvement in systemic sclerosis].
Guerini S; Cavazzana I; Venturelli C; Rozzi M; Turina S; Sottini L; Tardanico R; Franceschini F; Scolari F
G Ital Nefrol; 2007; 24(4):295-310. PubMed ID: 17659501
[TBL] [Abstract][Full Text] [Related]
11. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features and prognosis of patients with scleroderma renal crisis].
Roda-Safont A; Simeón-Aznar CP; Fonollosa-Plà V; Segarra-Medrano A; Vilardell-Tarrés M
Med Clin (Barc); 2011 Oct; 137(10):431-4. PubMed ID: 21596402
[TBL] [Abstract][Full Text] [Related]
13. Scleroderma renal crisis.
Mouthon L; Bussone G; Berezné A; Noël LH; Guillevin L
J Rheumatol; 2014 Jun; 41(6):1040-8. PubMed ID: 24833760
[TBL] [Abstract][Full Text] [Related]
14. Renal complications and scleroderma renal crisis.
Denton CP; Lapadula G; Mouthon L; Müller-Ladner U
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii32-5. PubMed ID: 19487221
[TBL] [Abstract][Full Text] [Related]
15. [Scleroderma renal crisis (SRC): hypertensive, normotensive].
Endo H
Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):656-60. PubMed ID: 11210764
[No Abstract] [Full Text] [Related]
16. Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment.
Walker JG; Ahern MJ; Smith MD; Coleman M; Pile K; Rischmueller M; Cleland L; Roberts-Thomson PJ
Intern Med J; 2003; 33(5-6):216-20. PubMed ID: 12752889
[TBL] [Abstract][Full Text] [Related]
17. An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis.
Denton CP; Engelhart M; Tvede N; Wilson H; Khan K; Shiwen X; Carreira PE; Diaz Gonzalez F; Black CM; van den Hoogen FH
Ann Rheum Dis; 2009 Sep; 68(9):1433-9. PubMed ID: 18782794
[TBL] [Abstract][Full Text] [Related]
18. [Renal involvement in scleroderma].
Boffa JJ; Rossert J
Rev Prat; 2002 Nov; 52(17):1910-4. PubMed ID: 12532868
[TBL] [Abstract][Full Text] [Related]
19. [A retrospective clinical analysis of 16 patients with scleroderma renal crisis].
Zhou J; Xu D; Hou Y; Wang Q; Li M; Zeng X
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):125-9. PubMed ID: 25907843
[TBL] [Abstract][Full Text] [Related]
20. [Renal manifestations of systemic autoimmune disease: diagnosis and therapy].
O'Callaghan CA
Nephrol Ther; 2006 Jul; 2(3):140-51. PubMed ID: 16890139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]